trending Market Intelligence /marketintelligence/en/news-insights/trending/nYtXGhQVhRykOFlPqlZNWQ2 content esgSubNav
In This List

Intellia Therapeutics director resigns

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Intellia Therapeutics director resigns

Moncef Slaoui resigned as a board member of Intellia Therapeutics Inc. due to a conflict of interest, effective Aug. 7.

Slaoui was added to the board in July. His decision to resign did not result from any disagreement with the company on any matter relating to its operations, policies or practices.